Carlos A. Cardenas
Prostate cancer remains a significant global health concern, affecting millions of individuals worldwide, is the most frequently diagnosed cancer and the sixth leading cause of cancer-related deaths globally. It poses a significant health challenge, particularly for men over the age of 50, with over 1.4 million new cases and over 375,000 deaths reported annually [1]. Its prevalence and impact on patient's quality of life demand continuous research efforts to advance early detection methods and refine treatment strategies. In this editorial, we aim to shed light on current developments in prostate cancer detection tests and provide detailed insights into innovative management approaches. By highlighting these advancements, we hope to equip scientists and medical doctors with up-to-date information to optimize patient care and outcomes.
English 
Spanish 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi